Never has it been so hard to figure out what’s good for you. 10,000 steps a day or 7,000? More red meat or less? To use painkillers or not to use painkillers?

Increasingly it seems that medical advice is being issued based more on feelings and political ideology than scientific fact. In the  second part of their Tech in ‘26 series, Matt and Rich examine some of the headline treatments and advances we’re likely to see this year.

From new blood tests for dementia and associated brain shuttle treatments that can break the brain-blood barrier, to the expansion of GLP-1 and similar obesity treatments. Plus the future of primary care, with telemedicine going mainstream, and the role of AI in just about every part of medical research and diagnostics.